5 Pharmaceutical companies with insider buying during August 14-16 (SeekingAlpha) - Aug 19, 2012 - Depomed expects to have the results for its P2 trial in Parkinson's disease with DM-1992 before Q4 2012
Anticipated P2 data • Parkinson's Disease
|
|
Upcoming milestones
In January, the company announced the commencement of a Phase II trial in Parkinson's Disease with DM-1992, the company's proprietary formulation of levodopa/carbidopa. Enrollment in that trial is now complete and Depomed expects to have the results before the end of the year...
(IR5)
|